This document provides an investor presentation for Valeritas, a medical technology company focused on improving health and simplifying life for people with diabetes. It summarizes Valeritas' V-Go wearable insulin delivery device which addresses key unmet needs for patients with type 2 diabetes on insulin who are not achieving treatment goals. Clinical data shows V-Go delivers clinically-relevant A1C reductions with less insulin. The presentation outlines Valeritas' commercial strategy and leadership team, and highlights the significant market opportunity represented by the 4.5 million patients in the US with type 2 diabetes on insulin who are not achieving glycemic control.
Art 920 rev-i-valeritas investor presentation_final_02-27-18valeritasir
The document discusses improving health and simplifying life for people with diabetes through the use of Valeritas' V-Go wearable insulin delivery device. It notes that V-Go addresses key unmet needs for the 4.5 million patients in the US with type 2 diabetes who are on insulin but not achieving their A1C goals, representing a $16.5 billion market opportunity. Physician feedback indicates that V-Go's greatest benefits are that it reduces multiple daily injections, does not require patients to carry insulin and needles, allows for discreet mealtime dosing, and is easy to learn and use.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. The QE Index is expected to see further retracement if it fails to reclaim 12,700. Al Khalij Commercial Bank rebounded and may test resistance at QR24. The Al Rayan Islamic Index recovered losses but needs to clear resistances to resume its uptrend. Ooredoo extended losses and may continue drifting lower to test support at QR141.80. Masraf Al Rayan cleared resistance and could rise to QR51 if support at QR49.75 holds. Nakilat breached support at QR23.40 and may continue heading lower to QR22.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. It finds the QE Index may continue bouncing back toward 13,550-13,580 after recovering for two straight sessions. Commercial Bank of Qatar is also expected to rebound after clearing a resistance level. Meanwhile, the Al Rayan Islamic Index is seen as neutral and may oscillate within a narrow range. Mazaya Qatar Real Estate is predicted to experience further pullback and drift lower.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider over the short-term. It analyzes the short-term trends for the QE Index, 6 stocks, the Al Rayan Islamic Index, and provides price targets and support and resistance levels. The analysis finds the QE Index and Al Rayan Index are in uptrends in the short-term and most stocks are expected to continue rising or bounce back, while QEWS may see a short-term pullback.
The document provides a technical analysis of the QE Index and key Qatari stocks. It identifies several stocks as experiencing short-term downmoves or pullbacks, including Industries Qatar, Qatar Electricity & Water Co., Nakilat, and Milaha. The QE Index and Al Rayan Islamic Index are also seen as experiencing short-term pullbacks. Technical indicators like the RSI and MACD are cited to support the analysis for most stocks. Contact information is provided at the end.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for each as uptrending or downtrending based on price movements and technical indicators. For most stocks analyzed, the short-term trend is identified as uptrending, with a few like Industries Qatar identified as downtrending or flat. Support and resistance levels are also identified for each to watch in the short-term.
The document provides a technical analysis of the QE Index, key Qatari stocks, and indices to identify short-term trading opportunities. It finds the QE Index is neutral in the short-term as it trades near support levels. Nakilat is predicted to pull back further as it broke below supports. The Al Rayan Islamic Index is also neutral as it reclaimed its 55-day moving average. QIBK is expected to pull back after breaking below its 21-day moving average, while GISS may continue its uptrend after reaching a new high.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. The QE Index is neutral in the short-term as it closed near an important support level of 12,750. Industries Qatar is rated as a short-term pullback as it breached an important support. The Al Rayan Islamic Index is neutral as it needs to reclaim a key support level to maintain upward momentum. Qatar Insurance is rated as a short-term rebound as it found support and rebounded over 1%. Barwa Real Estate is rated as a short-term pullback as it drifted lower and breached multiple supports.
Art 920 rev-i-valeritas investor presentation_final_02-27-18valeritasir
The document discusses improving health and simplifying life for people with diabetes through the use of Valeritas' V-Go wearable insulin delivery device. It notes that V-Go addresses key unmet needs for the 4.5 million patients in the US with type 2 diabetes who are on insulin but not achieving their A1C goals, representing a $16.5 billion market opportunity. Physician feedback indicates that V-Go's greatest benefits are that it reduces multiple daily injections, does not require patients to carry insulin and needles, allows for discreet mealtime dosing, and is easy to learn and use.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. The QE Index is expected to see further retracement if it fails to reclaim 12,700. Al Khalij Commercial Bank rebounded and may test resistance at QR24. The Al Rayan Islamic Index recovered losses but needs to clear resistances to resume its uptrend. Ooredoo extended losses and may continue drifting lower to test support at QR141.80. Masraf Al Rayan cleared resistance and could rise to QR51 if support at QR49.75 holds. Nakilat breached support at QR23.40 and may continue heading lower to QR22.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. It finds the QE Index may continue bouncing back toward 13,550-13,580 after recovering for two straight sessions. Commercial Bank of Qatar is also expected to rebound after clearing a resistance level. Meanwhile, the Al Rayan Islamic Index is seen as neutral and may oscillate within a narrow range. Mazaya Qatar Real Estate is predicted to experience further pullback and drift lower.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider over the short-term. It analyzes the short-term trends for the QE Index, 6 stocks, the Al Rayan Islamic Index, and provides price targets and support and resistance levels. The analysis finds the QE Index and Al Rayan Index are in uptrends in the short-term and most stocks are expected to continue rising or bounce back, while QEWS may see a short-term pullback.
The document provides a technical analysis of the QE Index and key Qatari stocks. It identifies several stocks as experiencing short-term downmoves or pullbacks, including Industries Qatar, Qatar Electricity & Water Co., Nakilat, and Milaha. The QE Index and Al Rayan Islamic Index are also seen as experiencing short-term pullbacks. Technical indicators like the RSI and MACD are cited to support the analysis for most stocks. Contact information is provided at the end.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for each as uptrending or downtrending based on price movements and technical indicators. For most stocks analyzed, the short-term trend is identified as uptrending, with a few like Industries Qatar identified as downtrending or flat. Support and resistance levels are also identified for each to watch in the short-term.
The document provides a technical analysis of the QE Index, key Qatari stocks, and indices to identify short-term trading opportunities. It finds the QE Index is neutral in the short-term as it trades near support levels. Nakilat is predicted to pull back further as it broke below supports. The Al Rayan Islamic Index is also neutral as it reclaimed its 55-day moving average. QIBK is expected to pull back after breaking below its 21-day moving average, while GISS may continue its uptrend after reaching a new high.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. The QE Index is neutral in the short-term as it closed near an important support level of 12,750. Industries Qatar is rated as a short-term pullback as it breached an important support. The Al Rayan Islamic Index is neutral as it needs to reclaim a key support level to maintain upward momentum. Qatar Insurance is rated as a short-term rebound as it found support and rebounded over 1%. Barwa Real Estate is rated as a short-term pullback as it drifted lower and breached multiple supports.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider over the short term. Several stocks are recommended as short term buys, expected to bounce back or continue their uptrend, including Masraf Al Rayan, Qatar Islamic Bank, Industries Qatar, and Medicare Group. The QE Index and Al Rayan Islamic Index are also assessed to continue their positive momentum and rally further.
The document provides a technical analysis of the QE Index and key Qatari stocks, identifying short-term pull backs. It analyzes trends in the QE Index, Gulf International Services, Al Rayan Islamic Index, Milaha, Industries Qatar, and Commercial Bank of Qatar, noting they have breached support levels and predicting further downward movement. Momentum indicators for the stocks are also moving in bearish directions, showing no signs of immediate trend reversal.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends and provides support and resistance levels. The QE Index, Al Rayan Islamic Index, and most mentioned stocks are seen in a short-term downtrend or pullback, with the exception of Masraf Al Rayan, Qatari Investors Group, and a few others which are expected to bounce back or see buying interest. Technical indicators like RSI, MACD, and moving averages are also referenced to support the analyses.
The document provides a technical analysis of the QE Index and key Qatari stocks. It analyzes the short-term and long-term trends of the indexes and stocks, identifying levels of support and resistance. For each, it suggests whether the trend is bullish and likely to continue upward or if a pullback or correction is expected in the short-term.
The document provides a technical analysis of the QE Index and key stocks to consider in Qatar. It summarizes recent performance and provides short-term outlooks. For the QE Index, it predicts a potential higher move if the index sustains above 13,100, but risks consolidation below that level. For several stocks discussed, including MCGS, QIGD and DHBK, it outlines recent gains and resistance levels to watch in the short-term for further upmoves, but risks if those levels are broken. The document also lists support and resistance levels for 19 Qatari stocks to gauge short and long-term trends.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. For the QE Index and Al Rayan Islamic Index, it recommends a neutral short-term outlook as the indexes need to hold certain support levels to advance further. For individual stocks, it recommends short-term upmoves for Barwa Real Estate, Commercial Bank of Qatar, and Nakilat as they have broken resistances, while recommending downmoves for Gulf International Services and some other banks.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for various indexes and stocks, finding the QE Index and Al Rayan Islamic Index to be in uptrends, while Qatari Investors Group is in a short-term downtrend. It also provides commentary on the short-term trends for individual stocks like Al Khalij Commercial Bank, Gulf International Services, and Commercial Bank of Qatar. Technical indicators like moving averages, RSI, and MACD are referenced for each analysis.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for several indices and stocks, noting whether they are in an uptrend or pullback. For indices and most stocks, it finds they are in an uptrend and identifies nearby support and resistance price levels. It provides contact information for the research department that produced the analysis.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. The QE Index is neutral in the short-term as it gained but needs to surpass resistance for confirmation. Barwa Real Estate is in an upmove as it breached resistance and approaches the next level. The Al Rayan Islamic Index extended gains, reaching a new high, and may continue advancing if it holds above recent resistance breakouts. Qatar Insurance is facing a pullback as it trades below its 21-day moving average. Qatar Islamic Bank cleared resistances on large volume and could confirm its upmove by breaching a level near its 21-day moving average. Industries Qatar witnessed
The document provides a technical analysis of the QE Index and key Qatari stocks. It identifies several stocks as experiencing a short-term pullback, including Industries Qatar, Qatar Islamic Bank, Al Rayan Islamic Index, Ooredoo, and Qatar Islamic Bank. The analysis also notes that Gulf International Services may experience a short-term rebound if it remains above a support level of QR111.90. Overall, the analysis offers short-term price predictions and identifies support and resistance levels for several Qatari stocks and indices.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes several stocks and indexes, including the QE Index, Commercial Bank of Qatar, Al Rayan Islamic Index, Gulf International Services, Masraf Al Rayan, Ooredoo, and others. For each, it provides the short-term outlook (neutral, pullback, rebound, etc.), recent price movements, support and resistance levels, and whether technical indicators suggest further upside or downside. The analysis will help traders and investors identify opportunities and guide their trading decisions.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for each, including whether they are in an uptrend, downtrend, or pullback. The QE Index is in an uptrend with support at 12,100 and resistance at 12,300. Nakilat broke out above resistance but investors should watch for a move back below support of QR21.15. The Al Rayan Islamic Index is in an uptrend with support at 3,700 and resistance at 4,000.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It summarizes that the QE Index and most mentioned stocks are showing short-term upmoves based on technical indicators such as moving averages and momentum signals. It provides details on technical levels and indicators for each stock, identifying short-term support and resistance levels. The analysis recommends watching certain levels that could trigger continued buying or signals of trend reversal.
The document provides a technical analysis of the QE Index and several key Qatari stocks. It analyzes the short-term trends for each as neutral, pullback, neutral, uptrend, bounce back, and pullback respectively. It also notes technical indicators like support/resistance levels, moving averages, and candlestick patterns to support the short-term outlook for each stock. The analysis is intended to help identify trading opportunities over the coming days and weeks.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider in the short term. It finds that the QE Index and most mentioned stocks are in a short-term downtrend based on declines in price and bearish signals from momentum indicators. Specific stocks like IQCD, MERS, DHBK and BRES are suggested for short term sells with identified price targets and stop losses. The analysis also notes support and resistance levels for the indexes and stocks.
The document provides a technical analysis of the QE Index, key Qatari stocks, and Islamic indexes. It notes that the QE Index ended lower but is currently rangebound between 9,770 and 9,700. United Development Co. rebounded from support and may test resistance. The QERI Islamic Index slipped marginally and is consolidating near its 55-day moving average. Qatar International Islamic Bank opened lower but recovered and may test resistance if support holds. Qatar Islamic Bank dipped below support and technical indicators point lower. Gulf International Services tagged a new high but reversed and may correct toward an ascending trendline.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, offering the following assessments:
- The QE Index gained points after four days of falling and may continue to rally if it moves above 12,650, otherwise it could retreat to test 12,600.
- Gulf International Services advanced after consolidation and may surpass resistance at QR90 to reach QR93, but could consolidate if it fails to move above QR90.
- The QERI Index rebounded after five days of losses but needs to move above 4,200 to gain momentum, or it risks consolidating and retesting 4,150.
- Nakilat cleared an interim resistance and may test QR
The document provides a technical analysis of the QE Index and key Qatari stocks to consider for the short term. It analyzes recent price movements and trends to identify stocks that are poised to bounce back or rebound within the next 1-3 weeks. Specifically, it suggests the QE Index, Al Rayan Islamic Index, Medicare Group, Qatar Islamic Bank, Al Khalij Commercial Bank, and Vodafone Qatar may extend recent gains and rise further in the short term.
- The document provides a technical analysis of the QE Index, key Qatari stocks, and their short-term trends. It analyzes whether the trends are neutral, an uptrend, or a pullback/downtrend.
- For most stocks, it identifies short-term support and resistance levels. It recommends buy/sell targets and stop loss levels based on the technical analysis.
- The analysis is based on indicators like simple moving averages, RSI, and MACD to determine trend direction and strength. It provides both a historical trend analysis and near-term outlook.
The document provides a technical analysis of the QE Index, key Qatari stocks, and indices. It notes that the QE Index closed higher but needs to hold above psychological and moving average levels to continue rising. Ooredoo respected support and may rise further if it holds above resistance. The QERI Index advanced but failed to sustain above moving averages, requiring confirmation before accumulation is recommended. Doha Bank and Barwa Real Estate showed bounce back potential but need to close above resistance levels. Gulf International Services may test moving averages if it remains below resistance.
Aurora Cannabis presented their strategy and progress at an investor presentation in November 2017. They outlined their goal of becoming a globally dominant cannabis company through agility, innovation, execution, and expansion. Since August 2016, Aurora had rapidly grown from one facility with 4,800 kg annual capacity to three facilities with over 9,000 kg capacity, expanded to three countries, and increased revenues from $3.1 million to over $8 million. Going forward, Aurora planned to continue their rapid domestic and international expansion, pursue product differentiation, and make strategic acquisitions to capitalize on the large global cannabis market opportunity.
Inspirato is a luxury travel subscription company that provides access to over 600 luxury vacation homes and hotels. The company was founded in 2011 and has grown to over 25,000 subscribers. Inspirato utilizes proprietary technology to offer subscribers flexible travel with no nightly rates or taxes. The company aims to deliver exceptional luxury travel experiences through superior service and certainty.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider over the short term. Several stocks are recommended as short term buys, expected to bounce back or continue their uptrend, including Masraf Al Rayan, Qatar Islamic Bank, Industries Qatar, and Medicare Group. The QE Index and Al Rayan Islamic Index are also assessed to continue their positive momentum and rally further.
The document provides a technical analysis of the QE Index and key Qatari stocks, identifying short-term pull backs. It analyzes trends in the QE Index, Gulf International Services, Al Rayan Islamic Index, Milaha, Industries Qatar, and Commercial Bank of Qatar, noting they have breached support levels and predicting further downward movement. Momentum indicators for the stocks are also moving in bearish directions, showing no signs of immediate trend reversal.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends and provides support and resistance levels. The QE Index, Al Rayan Islamic Index, and most mentioned stocks are seen in a short-term downtrend or pullback, with the exception of Masraf Al Rayan, Qatari Investors Group, and a few others which are expected to bounce back or see buying interest. Technical indicators like RSI, MACD, and moving averages are also referenced to support the analyses.
The document provides a technical analysis of the QE Index and key Qatari stocks. It analyzes the short-term and long-term trends of the indexes and stocks, identifying levels of support and resistance. For each, it suggests whether the trend is bullish and likely to continue upward or if a pullback or correction is expected in the short-term.
The document provides a technical analysis of the QE Index and key stocks to consider in Qatar. It summarizes recent performance and provides short-term outlooks. For the QE Index, it predicts a potential higher move if the index sustains above 13,100, but risks consolidation below that level. For several stocks discussed, including MCGS, QIGD and DHBK, it outlines recent gains and resistance levels to watch in the short-term for further upmoves, but risks if those levels are broken. The document also lists support and resistance levels for 19 Qatari stocks to gauge short and long-term trends.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. For the QE Index and Al Rayan Islamic Index, it recommends a neutral short-term outlook as the indexes need to hold certain support levels to advance further. For individual stocks, it recommends short-term upmoves for Barwa Real Estate, Commercial Bank of Qatar, and Nakilat as they have broken resistances, while recommending downmoves for Gulf International Services and some other banks.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for various indexes and stocks, finding the QE Index and Al Rayan Islamic Index to be in uptrends, while Qatari Investors Group is in a short-term downtrend. It also provides commentary on the short-term trends for individual stocks like Al Khalij Commercial Bank, Gulf International Services, and Commercial Bank of Qatar. Technical indicators like moving averages, RSI, and MACD are referenced for each analysis.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for several indices and stocks, noting whether they are in an uptrend or pullback. For indices and most stocks, it finds they are in an uptrend and identifies nearby support and resistance price levels. It provides contact information for the research department that produced the analysis.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, giving short-term outlooks. The QE Index is neutral in the short-term as it gained but needs to surpass resistance for confirmation. Barwa Real Estate is in an upmove as it breached resistance and approaches the next level. The Al Rayan Islamic Index extended gains, reaching a new high, and may continue advancing if it holds above recent resistance breakouts. Qatar Insurance is facing a pullback as it trades below its 21-day moving average. Qatar Islamic Bank cleared resistances on large volume and could confirm its upmove by breaching a level near its 21-day moving average. Industries Qatar witnessed
The document provides a technical analysis of the QE Index and key Qatari stocks. It identifies several stocks as experiencing a short-term pullback, including Industries Qatar, Qatar Islamic Bank, Al Rayan Islamic Index, Ooredoo, and Qatar Islamic Bank. The analysis also notes that Gulf International Services may experience a short-term rebound if it remains above a support level of QR111.90. Overall, the analysis offers short-term price predictions and identifies support and resistance levels for several Qatari stocks and indices.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes several stocks and indexes, including the QE Index, Commercial Bank of Qatar, Al Rayan Islamic Index, Gulf International Services, Masraf Al Rayan, Ooredoo, and others. For each, it provides the short-term outlook (neutral, pullback, rebound, etc.), recent price movements, support and resistance levels, and whether technical indicators suggest further upside or downside. The analysis will help traders and investors identify opportunities and guide their trading decisions.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It analyzes the short-term trends for each, including whether they are in an uptrend, downtrend, or pullback. The QE Index is in an uptrend with support at 12,100 and resistance at 12,300. Nakilat broke out above resistance but investors should watch for a move back below support of QR21.15. The Al Rayan Islamic Index is in an uptrend with support at 3,700 and resistance at 4,000.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider. It summarizes that the QE Index and most mentioned stocks are showing short-term upmoves based on technical indicators such as moving averages and momentum signals. It provides details on technical levels and indicators for each stock, identifying short-term support and resistance levels. The analysis recommends watching certain levels that could trigger continued buying or signals of trend reversal.
The document provides a technical analysis of the QE Index and several key Qatari stocks. It analyzes the short-term trends for each as neutral, pullback, neutral, uptrend, bounce back, and pullback respectively. It also notes technical indicators like support/resistance levels, moving averages, and candlestick patterns to support the short-term outlook for each stock. The analysis is intended to help identify trading opportunities over the coming days and weeks.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider in the short term. It finds that the QE Index and most mentioned stocks are in a short-term downtrend based on declines in price and bearish signals from momentum indicators. Specific stocks like IQCD, MERS, DHBK and BRES are suggested for short term sells with identified price targets and stop losses. The analysis also notes support and resistance levels for the indexes and stocks.
The document provides a technical analysis of the QE Index, key Qatari stocks, and Islamic indexes. It notes that the QE Index ended lower but is currently rangebound between 9,770 and 9,700. United Development Co. rebounded from support and may test resistance. The QERI Islamic Index slipped marginally and is consolidating near its 55-day moving average. Qatar International Islamic Bank opened lower but recovered and may test resistance if support holds. Qatar Islamic Bank dipped below support and technical indicators point lower. Gulf International Services tagged a new high but reversed and may correct toward an ascending trendline.
The document provides a technical analysis of the QE Index and key Qatari stocks to consider, offering the following assessments:
- The QE Index gained points after four days of falling and may continue to rally if it moves above 12,650, otherwise it could retreat to test 12,600.
- Gulf International Services advanced after consolidation and may surpass resistance at QR90 to reach QR93, but could consolidate if it fails to move above QR90.
- The QERI Index rebounded after five days of losses but needs to move above 4,200 to gain momentum, or it risks consolidating and retesting 4,150.
- Nakilat cleared an interim resistance and may test QR
The document provides a technical analysis of the QE Index and key Qatari stocks to consider for the short term. It analyzes recent price movements and trends to identify stocks that are poised to bounce back or rebound within the next 1-3 weeks. Specifically, it suggests the QE Index, Al Rayan Islamic Index, Medicare Group, Qatar Islamic Bank, Al Khalij Commercial Bank, and Vodafone Qatar may extend recent gains and rise further in the short term.
- The document provides a technical analysis of the QE Index, key Qatari stocks, and their short-term trends. It analyzes whether the trends are neutral, an uptrend, or a pullback/downtrend.
- For most stocks, it identifies short-term support and resistance levels. It recommends buy/sell targets and stop loss levels based on the technical analysis.
- The analysis is based on indicators like simple moving averages, RSI, and MACD to determine trend direction and strength. It provides both a historical trend analysis and near-term outlook.
The document provides a technical analysis of the QE Index, key Qatari stocks, and indices. It notes that the QE Index closed higher but needs to hold above psychological and moving average levels to continue rising. Ooredoo respected support and may rise further if it holds above resistance. The QERI Index advanced but failed to sustain above moving averages, requiring confirmation before accumulation is recommended. Doha Bank and Barwa Real Estate showed bounce back potential but need to close above resistance levels. Gulf International Services may test moving averages if it remains below resistance.
Aurora Cannabis presented their strategy and progress at an investor presentation in November 2017. They outlined their goal of becoming a globally dominant cannabis company through agility, innovation, execution, and expansion. Since August 2016, Aurora had rapidly grown from one facility with 4,800 kg annual capacity to three facilities with over 9,000 kg capacity, expanded to three countries, and increased revenues from $3.1 million to over $8 million. Going forward, Aurora planned to continue their rapid domestic and international expansion, pursue product differentiation, and make strategic acquisitions to capitalize on the large global cannabis market opportunity.
Inspirato is a luxury travel subscription company that provides access to over 600 luxury vacation homes and hotels. The company was founded in 2011 and has grown to over 25,000 subscribers. Inspirato utilizes proprietary technology to offer subscribers flexible travel with no nightly rates or taxes. The company aims to deliver exceptional luxury travel experiences through superior service and certainty.
- Adgex Ltd is an Australian public company that acquires technologies in Russia and commercially applies them in markets in Australia, Asia, and Africa.
- They are seeking investment to complete signed contracts for locomotive production, metalworking, and generator production in order to transition to the next stage of capitalization without additional investments.
- The company owns several technologies and unique patents that allow them to implement practical market solutions for clients across various industries.
- The company update discusses Pacific Drilling's focus on operational excellence and cost management in a difficult market environment. They aim to minimize downtime and maximize rig efficiency to distinguish themselves.
- Cost reduction initiatives have delivered $32 million in savings so far in 2015, with a target of $75 million for the full year. This includes reductions in personnel, maintenance, and other expenses.
- Pacific Drilling has implemented "smart stacking" to reduce costs for idle rigs to less than $40,000 per day without requiring additional investment, keeping rigs ready to work within 90 days.
This document discusses how marketplaces are changing industries like retail, payments, transportation, and lending. It notes that marketplaces aim to change how people access these services in a more convenient, cost-efficient way. The document advocates that marketplaces will succeed by focusing on speed, customer experience, fairness, transparency, and cooperation between all parties.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Waywaya Management & Consulting, LLC is managed by Princess Viray and serves as a referral partner connecting private family offices to financing opportunities for projects focused on environmental, social and governance goals. Fiscus Holdings, Inc. is an offshore holding company for five funds called Fiscus Funds that were co-founded by Princess Viray. Fiscus Treasury I, LLC is a US-based company managed by Princess Viray to support asset and capital acquisitions of Fiscus Holdings. The funds aim to digitally transform revenue from physical assets via smart contracts on the blockchain.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial intelligence (AI) companies. All references to Tenet in this news release, unless explicitly specified, includes Tenet and all its subsidiaries. Tenet's subsidiaries provide various analytics and AI-based services to businesses and financial institutions through various Business Hubs™ to create a global ecosystem where analytics and AI are used to create opportunities and facilitate B2B transactions among its members. For more information: http://www.tenetfintech.com
This document summarizes an investor presentation for MedReleaf Corp.'s initial public offering. Key points include that MedReleaf is seeking to raise approximately $100 million Canadian dollars in an IPO priced between $9.50-$10.50 per share. Proceeds will be used to expand MedReleaf's existing cannabis production and manufacturing facilities, fund clinical research, and for general working capital purposes. The presentation highlights MedReleaf's current operational success and leadership in the Canadian medical cannabis market.
This document summarizes an investor presentation for MedReleaf Corp.'s initial public offering. It outlines key details of the offering such as the issuer, selling shareholders, offering price range between $9.50-$10.50 per share, expected size of $100 million, and intended use of proceeds. It also highlights MedReleaf's leadership in the Canadian medical cannabis market through its high quality indoor cultivation facilities, low production costs, revenue growth while maintaining profitability, and plans for expansion.
This document summarizes an investor presentation for MedReleaf Corp.'s initial public offering. Key points include that MedReleaf is offering shares at $9.50-$10.50 per share to raise approximately $100 million Canadian dollars, which will be used to expand their existing cannabis production facility, develop new products, and for general corporate purposes. Investors are warned to consider the risks disclosed in the prospectus and that forward-looking statements are based on estimates and assumptions. The presentation highlights MedReleaf's current operational success, low production costs, high market share, and near-term expansion plans.
Objective: The investment objective of Avasar Hudson Partners, LP (‘Fund’) is to generate superior long term returns while minimizing realized investment losses.
GENERAL DISCLAIMER: The information contained herein regarding Avasar Hudson Partners, LP (the "Fund") has been prepared solely for illustration and discussion purposes and is not intended to be, nor should it be construed or used as, an offer to buy or sell or a solicitation of an offer to buy or sell any limited partnership interests in the Fund.
Avasar Partners, 157 Columbus Ave, 4th Floor, New York, NY 10023 Tel: 646‐216‐9890 Email: jjani@avasarpartners.com
Investment Strategy: The fund’s investment manager utilizes a bottom up fundamental research driven Long/Short equity strategy focusing primarily on US equities preferably of small and midcap companies.
Portfolio: Highly selective best ideas portfolio with concentrated positions (<10 Longs). Net exposure is variable based upon opportunities through the cycle. Risk is managed at the investment and portfolio level to limit realized losses at both levels.
Investment Process: Repeatable investment process of Buying equities at attractive prices; Creating a knowledge advantage through detailed research often over years; Identifying value enhancing catalysts; Sizing the position given the opportunity; Patiently managing through volatility to realize gains.
Team: The team has over 15 years of Investment and Credit experience through market cycle and multiple crises. Sidarth Kapoor, CFA, as Portfolio Manager managed a $300 million equity portfolio at Principled Capital Management. Jatin Jani, CFA, as Investment Analyst directly supported investments of $200 million at Principled Capital Management. Both worked in the Credit Division of Mizuho Corporate Bank.
Commitment: The Principals are committed towards meeting their objective with skin in the game and a focus to win.
Bragg Gaming Group provides a turnkey online gaming solution for operators through its proprietary iGaming platform. It has experienced strong revenue and EBITDA growth in recent years due to a growing customer base that has tripled in size. Bragg's business model is highly scalable and profitable, earning revenue through sharing a percentage of gross gaming revenue from operators using its platform. It aims to continue growing its core business and diversifying into new markets like the US and Canada through technology, partnerships, and acquisitions.
Art 1236 rev b-valeritas investor deck 2.0 final_053118valeritasir
Valeritas is a medical device company that provides the V-Go wearable insulin delivery device to help improve health and simplify life for people with diabetes. The company has validated a new high-touch sales model that is driving accelerating revenue growth. Valeritas expects over 30% revenue growth in 2018 to approximately $26-28 million based on the significant and underserved US market opportunity of over 5.6 million Type 2 diabetes patients on insulin therapy. Clinical evidence demonstrates that V-Go improves A1c control with less insulin compared to standard treatment, and is more cost-effective.
Aurora investor presentation - April 2018hughcarter
The document provides an overview of Aurora Cannabis Inc., a company focused on the production and distribution of medical cannabis. Key points:
- Aurora has over 280,000 kg per year of funded production capacity across several facilities.
- The company pursues growth through innovation, execution, expansion internationally and through acquisitions. It has acquired 8 companies and made 7 strategic investments.
- Aurora is well positioned for international growth, with existing sales or operations in Germany, Denmark, Italy, Australia, Cayman Islands, and South Africa. It aims to capitalize on medical cannabis markets in Europe and globally.
The document provides an overview of Aurora Cannabis Inc., a leading licensed producer of medical cannabis products in Canada. It highlights Aurora's:
1. Over 280,000 kg per year of funded production capacity across several facilities.
2. Focus on innovation in production, customer experience, and strategic partnerships.
3. Rapid growth and expansion strategy through domestic capacity increases, international markets, vertical integration and acquisitions.
Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada. We own and operate nine community-based clinics across four provinces where our team of health professionals work together to help patients by using a variety of evidence-based approaches.
Bragg Gaming Group is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg's main portfolio asset is ORYX Gaming, an innovative business-to-business gaming technology platform and casino content aggregator. Through this brand and targeted acquisitions, Bragg is focused on becoming a leader within the evolving global gaming industry.
Medirom Healthcare Technologies Inc. Investor Presentationssusera2656e
- Fall Detection
- SOS Button
- Heart Rate Alert
Time Monitoring
Logistics/
Transportation
Hospitals/
Nursing Homes
Gyms/
Wellness Centers
16
MEDIROM
HEALTHCARE
TECHNOLOGIES
INC.
MOTHER Bracelet can be introduced in various sectors to provide 24/7 health monitoring and improve operational efficiency.
- Hospitals/Nursing Homes: Replace manual rounds/checks with automated alerts. Improve patient safety and care quality.
- Logistics/Transportation: Monitor drivers' health in real-time. Detect emergencies and ensure timely medical response.
- Gyms/
Art 1236 rev c-valeritas investor deck 2.0_final_080618 web versionvaleritasir
Valeritas is a medical technology company focused on improving health and simplifying life for people with diabetes. Their flagship product, V-Go, is a wearable insulin delivery device for patients with type 2 diabetes. The presentation discusses Valeritas' significant market opportunity in the global diabetes pandemic, validates their new high-touch sales model which is driving accelerating revenue growth, and presents their attractive financial profile and path to profitability. Key risks to their projections include reliance on V-Go for revenue, ability to retain customers and achieve market acceptance, and manufacturing risks.
Art 1236 rev a-valeritas investor deck 2.0 final_031218bvaleritasir
Valeritas is a medical technology company focused on improving health and simplifying life for people with diabetes. Their flagship product, V-Go, is a wearable insulin delivery device that provides both basal and bolus insulin through a single-use, disposable patch. V-Go aims to help the millions of type 2 diabetes patients in the US who take insulin but struggle with adherence to multiple daily injections. Valeritas believes V-Go can become the preferred insulin delivery method for these patients by eliminating the need for injections. They are currently growing revenue quarter-over-quarter and targeting a $1.6 billion market opportunity by achieving a 15% share of the type 2 diabetes patients in the US who are not reaching their
Art 1236 rev a-valeritas investor deck 2.0 final_031218bvaleritasir
Valeritas is a medical technology company focused on improving health and simplifying life for people with diabetes. Their flagship product, V-Go, is a wearable insulin delivery device that provides both basal and bolus insulin through a single-use, disposable patch. V-Go aims to help the millions of type 2 diabetes patients in the US who take insulin but struggle with adherence to multiple daily injections. Valeritas believes V-Go can become the preferred insulin delivery method for these patients by eliminating the need for injections. They are currently growing revenue quarter-over-quarter and targeting a $1.6 billion market opportunity by achieving a 15% share of the type 2 diabetes patients in the US who are not reaching their
Valeritas provides a corporate presentation on their V-Go insulin delivery device. Key points include:
- V-Go is a single-use, fully disposable insulin delivery device worn like a patch that provides 24-hour basal and bolus insulin delivery with no programming.
- It is designed to simplify insulin delivery for patients with type 2 diabetes compared to multiple daily injections, improving adherence and health outcomes.
- With over 4.5 million patients in the US with type 2 diabetes taking insulin but not at glucose goals, V-Go represents a significant market opportunity of over $1 billion if it captures 15% market share.
- Clinical studies show V-Go lowers A1C, improves quality of
Art 920 rev-g-valeritas-investor-presentation_final_11.03.17valeritasir
V-Go is a wearable insulin delivery device that addresses unmet needs for the 4.5 million patients in the US with type 2 diabetes on insulin who are not achieving their A1C goals. It provides both basal and bolus insulin delivery in a discreet, easy-to-use device to improve poor adherence commonly seen with multiple daily injections. Clinical data shows patients achieve better glycemic control and report high satisfaction with V-Go's convenience and ability to fit their lifestyle.
Art 920 rev-d-valeritas investor presentation_final_04.03.17valeritasir
Valeritas is an investor presentation for NASDAQ: VLRX discussing their V-Go wearable insulin delivery device. In 3 sentences:
Valeritas provides a simple, discreet and easy-to-use insulin delivery device called V-Go that has strong clinical data showing reductions in A1C levels. V-Go has established reimbursement and is a cost-effective option for both patients and payors. The presentation outlines Valeritas' commercial strategy and financial profile, demonstrating potential for revenue growth while reducing operating expenses and cash burn.
Art 923 rev-c-updating investor presentation on valeritas website_final_12.05.16valeritasir
V-Go is a single-use, fully disposable insulin delivery device that provides basal and bolus insulin. It addresses the needs of the 4.6 million Type 2 diabetes patients in the US who require insulin but are not achieving treatment goals. Extensive clinical data shows V-Go lowers A1C levels and total daily insulin dose. It has established reimbursement through pharmacy benefits, making it cost-neutral for payors and patients compared to insulin pens. Valeritas sees significant growth opportunities by expanding its sales force to reach more prescribers.
Valeritas Investor Presentation August 2016valeritasir
This document provides an investor presentation for Valeritas Holdings, Inc. discussing their V-Go disposable insulin delivery device. It highlights the large market opportunity in the Type 2 diabetes market, the clinical benefits shown to improve A1C and quality of life, and the established reimbursement and commercial infrastructure. The presentation provides an overview of the company's commercialization progress and strategy to expand adoption and sales of V-Go as a simple, discreet, cost-effective basal-bolus insulin delivery option.
Valeritas is presenting their V-Go insulin delivery device to investors. The device addresses unmet needs for the 4.6 million type 2 diabetes patients in the US who require basal and bolus insulin but are not achieving optimal blood sugar control. Extensive clinical studies show that switching to V-Go significantly reduces A1C levels and total daily insulin dose compared to multiple daily injections, improving health outcomes and quality of life. Valeritas has commercialized V-Go in the US and aims to capitalize on the large $15 billion market opportunity for these patients through a focused commercial strategy and efficient manufacturing model.
1) The document provides confidential information about Valeritas, Inc. to shareholders, including an overview of their V-Go insulin delivery device, clinical data demonstrating its effectiveness at lowering A1C levels and daily insulin doses, and the experience and focus of the leadership team.
2) Valeritas believes V-Go is well-positioned for success due to its ability to address unmet needs in the large type 2 diabetes market, its demonstrated commercial traction, established reimbursement, and capital efficient strategy.
3) Clinical studies show patients experienced statistically significant improvements in A1C levels and reductions in daily insulin needs after switching to V-Go from multiple daily injections.
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdfSOFTTECHHUB
The world of blockchain and decentralized technologies is about to witness a groundbreaking event. ZKsync, the pioneering Ethereum Layer 2 network, has announced the highly anticipated airdrop of its native token, ZK. This move marks a significant milestone in the protocol's journey, empowering the community to take the reins and shape the future of this revolutionary ecosystem.
Methanex is the world's largest producer and supplier of methanol. We create value through our leadership in the global production, marketing and delivery of methanol to customers. View our latest Investor Presentation for more details.
UnityNet World Environment Day Abraham Project 2024 Press ReleaseLHelferty
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
UnityNet World Environment Day Abraham Project 2024 Press Release
May 2017 Investor Presentation
1. CONFIDENTIAL – AUTHORIZED USE ONLY
I m p r o v i n g h e a l t h a n d s i m p l i f y i n g l i f e f o r p e o p l e w i t h d i a b e t e s
Investor Presentation
NASDAQ: VLRX
May 2017
3. 3
▫ Significantly de‐risked commercial stage company
– $19.6M revenue & 35.5% Gross Margins in 2016
– > 11 million V‐Go devices dispensed to patients
– Positioned for substantial growth opportunities
▫ Targeting patients with Type 2 diabetes on insulin not at goal
– ~4.5M in the U.S. on insulin that are not at their A1C goal
▫ Established reimbursement cost neutral to patients & payors
– commercial and Medicare (under Medicare Part D)
– primarily distributed at retail pharmacy
▫ Robust clinical data: V‐Go® delivers clinically‐relevant A1C
reductions with less insulin
▫ Capital‐efficient commercial strategy gaining traction with
demonstrated growth in targeted accounts
Valeritas with V‐Go® Wearable Insulin Delivery device
Compelling Opportunity in Type 2 Diabetes Market
11. 11
Robust Clinical Data Validates the Ability of V‐Go® to Deliver
Clinically Relevant Reductions in A1C with Less Insulin
UPP6 UMASS7
8.8%
N=23
3 months
10.7%
N=14
3 months
-0.7*
-1.8*
-1.4
-1.6
-0.8
-1.2
-2.4
-1.6
9.7%
N= 83
~ 5 months
VALIDATE 12
9.6%
N=204
~ 7 months
ChangeinA1C
NEFEDA4
9.1%
N=69
NR
Jones5
8.9%
N=26
3 months
Ray8
1. Grunberger G, et al. Poster presented at AACE 23rd Annual Scientific Meeting, May 2014. 2. Lajara R, et al. Diabetes Therapy. 2015;6(4):531-545. 3. Harrison C,
et al. Poster presented at AACE 26th Annual Scientific Meeting, May 2017. 4. Sutton D, et al. Poster presented at 76th Scientific Sessions of the ADA, June 2016. 5.
Sink J, et al Poster Presented at Diabetes Technology Meeting, Nov. 2014. 6. Rosenfeld CR, et al. Endocr Pract. 2012;18(5):660-667. 7. Omer A, et al. Poster presented
at: ADA 73rd Scientific Sessions, June 2013. 8. Ray R, et al. Abstract published at 75th Scientific Sessions of the ADA, June 2015. 9. Data on file, Valeritas. Inc.
SIMPLE1
8.8%
N=87
3 months
EVIDENT3
9.7%
N=84
~8 months
Baseline Insulin Dose U/day: SIMPLE-62, VALIDATE 1-99, EVIDENT- 67, NEFEDA-86, Jones-76, UPP-49, UMASS-119, and Ray-74
*HbA1c change reported using least square means. †Insulin change reported based on comparison to prescribed upper limit at baseline
NR= Not reported
Insulin
Change 18% 41%† 22%9 20% 13% 46% 32%7%
20. 20
V‐Go® Link(2)V‐Go® V‐Go® Prefill(2)
• Prefilled insulin cartridge would
eliminate filling step
• No V‐Go® EZ Fill refrigeration
• Lower number of co‐pays(1)
• Would provide revenue from
insulin
• Could expand target population
• Extends patent life to 2032
(1) Assumes V‐Go devices and insulin cartridges packaged in a single box under a single NDC thereby potentially reducing the number of prescriptions and the number of co‐pays required per patient.
(2) Product currently under development.
Expected to:
• Provide connectivity to smart
phones, glucose meters and
other devices
• Permit tracking and reporting of
basal and bolus usage
• Increase patient adherence
• Be used as diagnostic tool to
make treatment adjustments
• Current product
• Filled by patient by transferring
insulin from vial using V‐Go®
EZ Fill
• Commercially available in U.S.
• Approved in E.U.
V‐Go® Line Extension Products Provide Path to the Broader
Diabetes & Insulin Market
22. 22
▫ Significantly de‐risked commercial stage company
– $19.6M revenue & 35.5% Gross Margins in 2016
• Can achieve 50% Gross Margin on approximately $13M quarterly revenue
• With current business plan and 45‐50 reps, Company can generate free cash flow after two
quarters with 50% gross margins
– > 11 million V‐Go devices dispensed to patients & positioned for growth
▫ Targeting patients with Type 2 diabetes on insulin not at goal
▫ Established reimbursement cost neutral to patients & payors
▫ Robust clinical data: V‐Go® delivers clinically‐relevant A1C
reductions with less insulin
▫ Capital‐efficient commercial strategy gaining traction with
demonstrated growth in targeted accounts
– Company expects double‐digit revenue growth in 2017 with majority of growth
occurring in 2H’17
Valeritas with V‐Go® Wearable Insulin Delivery device
Compelling Opportunity in Type 2 Diabetes Market
23. CONFIDENTIAL – AUTHORIZED USE ONLY
I m p r o v i n g h e a l t h a n d s i m p l i f y i n g l i f e f o r p e o p l e w i t h d i a b e t e s
Investor Presentation
NASDAQ: VLRX
May 2017
ART-920 Rev E 05/2017